Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2016860
Max Phase: Preclinical
Molecular Formula: C15H17N3OS
Molecular Weight: 287.39
Molecule Type: Small molecule
Associated Items:
ID: ALA2016860
Max Phase: Preclinical
Molecular Formula: C15H17N3OS
Molecular Weight: 287.39
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1NCC2(CCCCC2)c2sc(-c3cc[nH]n3)cc21
Standard InChI: InChI=1S/C15H17N3OS/c19-14-10-8-12(11-4-7-17-18-11)20-13(10)15(9-16-14)5-2-1-3-6-15/h4,7-8H,1-3,5-6,9H2,(H,16,19)(H,17,18)
Standard InChI Key: JPZGQBAWPFLBGW-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 287.39 | Molecular Weight (Monoisotopic): 287.1092 | AlogP: 3.08 | #Rotatable Bonds: 1 |
Polar Surface Area: 57.78 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 1.89 | CX LogP: 2.95 | CX LogD: 2.95 |
Aromatic Rings: 2 | Heavy Atoms: 20 | QED Weighted: 0.85 | Np Likeness Score: -0.68 |
1. Lindvall M, McBride C, McKenna M, Gesner TG, Yabannavar A, Wong K, Lin S, Walter A, Shafer CM.. (2011) 3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors., 2 (10): [PMID:24900258] [10.1021/ml200029w] |
Source(1):